Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels.
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):e2023868118. doi: 10.1073/pnas.2023868118.
Proc Natl Acad Sci U S A. 2021.
PMID: 34266948
Free PMC article.